Structure Based Design of Bioactive Compounds with applications in Health
In this direction, in silico tools were applied (Virtual screening of chemo-libraries with pharmacophore models, Molecular docking to target proteins, Molecular Dynamics Simulation, Prediction of physicochemical properties and QSAR) with the main purpose (a) the identification of hit compounds with affinity over a specific biological target, (b) guiding the optimization of precursors to lead compounds (hit-to-lead optimization), and (c) explaining the mechanisms of action of specific endogenous bioactive molecules or drugs.
The main protein targets were: (a) 14a Lanosterol dimethylase for the design of compounds with antimicrobial properties. Emphasis was given on resistant strains of the fungi Aspergillus Fumigatus and Candida Albicans. At the same time, based on structure-action studies, analogs of heterocyclic compounds (e.g., thiadiazoles, triazoles and oxadiazoles) were designed and synthesized (with external collaborators) and studied on microbial strains. (b) P2X7 receptor, 5 Lipoxygenase and cyclooxygenase 2 for the identification / design of compounds with anti-inflammatory action.